Spectrum of Hemoglobinopathies in Tertiary Care Hospitals of Rawalpindi and Islamabad  : Spectrum of Hemoglobinopathies

Tanveer Ul Haq Zia; Ammar Ahmed; Muhammad Ilyas; Hira Siyar; Haji Bahadar

doi:10.54393/pbmj.v7i03.1051

Authors

Tanveer Ul Haq Zia The University of Lahore, Islamabad Campus, Islamabad, Pakistan
Ammar Ahmed Ibadat International University, Islamabad, Pakistan
Muhammad Ilyas Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan
Hira Siyar Institute of Pharmaceutical Sciences, Khyber Medical University Peshawar, Pakistan
Haji Bahadar Institute of Pharmaceutical Sciences, Khyber Medical University Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v7i03.1051

Keywords:

Hemoglobinopathies, Sickle Cell Anemia, Thalassemia, Hemoglobin, Electrophoresis

Abstract

Hemoglobinopathies, including Thalassemia and sickle-cell syndromes are lifelong diseases with a significant impact on patients, families, and healthcare resources. Despite therapeutic progress, Pakistan, located within the Thalassemia belt, lacks comprehensive data on the epidemiology, clinical course, mortality, complications, and treatment outcomes of Thalassemia. Objective: To determine the frequency of haemoglobinopathies in Tertiary Care Hospital of Rawalpindi and Islamabad. Methods: A retrospective cross-sectional study of 7 months was conducted on the local population of Islamabad and Rawalpindi from January 2020 to July 2020. Total 600 patients referred for Hb electrophoresis were initially selected for study. Data from 300 patients were collected from PIMS Hospital, Islamabad, and 300 from Holy Family Hospital, Rawalpindi. Clinical information for each patient was recorded separately, data were statistically analyzed using Microsoft Excel version 2016 and graphs were made on GraphPad Prism version 08. Results: Out of 600 patients from Rawalpindi and Islamabad 227 (37.84%) patients were found to have hemoglobinopathies. Beta Thalassemia trait was the most common disorder among those with hemoglobinopathies (47.13%), followed by beta Thalassemia major (23.34%), sickle Beta Thalassemia (10.57%), sickle cell disease (6.6%), Hb D trait (5.28%), Hb D/beta Thalassemia (3.96%), Hb E trait (2.2%), and sickle cell trait (0.88%). Conclusions: The study showed a significantly high frequency of hemoglobinopathies in the capital city Islamabad and Rawalpindi. β- Thalassemia trait and β- Thalassemia major were found in high frequency among various hemoglobin disorders.

References

Piel FB. The present and future global burden of the inherited disorders of hemoglobin. Hematology/Oncology Clinics. 2016 Apr; 30(2): 327-41. doi: 10.1016/j.hoc.2015.11.004. DOI: https://doi.org/10.1016/j.hoc.2015.11.004

Modell B, 1 Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008 Jun; 86(6): 480-7.3. doi: 10.2471/BLT.06.036673. DOI: https://doi.org/10.2471/BLT.06.036673

Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Review of Hematology. 2010 Feb; 3(1): 103-17. doi: 10.1586/ehm.09.74. DOI: https://doi.org/10.1586/ehm.09.74

Forget BG and Bunn HF. Classification of the disorders of hemoglobin. Cold Spring Harbor Perspectives in Medicine. 2013 Feb; 3(2). doi: 10.1101/cshperspect.a011684. DOI: https://doi.org/10.1101/cshperspect.a011684

Rosenfeld LG, Bacal NS, Cuder MA, Silva AG, Machado ÍE, Pereira CA et al. Prevalência de hemoglobinopatias na população adulta brasileira: Pesquisa Nacional de Saúde 2014-2015. Revista Brasileira de Epidemiologia. 2019 Oct; 22: E190007-SUPL. doi: 10.1590/1980-549720190007.supl.2. DOI: https://doi.org/10.1590/1980-549720190007.supl.2

Aramayo-Singelmann C, Halimeh S, Proske P, Vignalingarajah A, Cario H, Christensen MO et al. Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives. Scientific Reports. 2022 Jun; 12(1): 9762. doi: 10.1038/s41598-022-13751-8. DOI: https://doi.org/10.1038/s41598-022-13751-8

Odièvre MH, Verger E, Silva-Pinto AC, Elion J. Pathophysiological insights in sickle cell disease. The Indian Journal of Medical Research. 2011 Oct; 134(4): 532.

Houwing ME, De Pagter PJ, Van Beers EJ, Biemond BJ, Rettenbacher E, Rijneveld AW et al. Sickle cell disease: clinical presentation and management of a global health challenge. Blood Reviews. 2019 Sep; 37: 100580. doi: 10.1016/j.blre.2019.05.004. DOI: https://doi.org/10.1016/j.blre.2019.05.004

Pecker LH and Little J. Clinical manifestations of sickle cell disease across the lifespan. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. 2018: 3-9. doi: 10.1007/978-3-319-62328-3_1. DOI: https://doi.org/10.1007/978-3-319-62328-3_1

Thein SL and Rees D. Haemoglobin and the inherited disorders of globin synthesis. Postgraduate Haematology. 2015 Dec: 72-97. doi: 10.1002/9781118853771.ch6. DOI: https://doi.org/10.1002/9781118853771.ch6

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti et al. Sickle cell disease. Nature Reviews Disease Primers. 2018 Mar; 4: 18010. doi: 10.1038/nrdp.2018.10. DOI: https://doi.org/10.1038/nrdp.2018.10

Ansari SH, Shamsi TS, Bohray M, Khan MT, Farzana T, Perveen K et al. Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications. International Journal of Molecular Epidemiology and Genetics. 2011 Nov; 2(4): 403-8. doi: 10.4103/0971-6866.100762. DOI: https://doi.org/10.4103/0971-6866.100762

Ehsan H, Wahab A, Anwer F, Iftikhar R, Yousaf MN. Prevalence of transfusion transmissible infections in beta-thalassemia major patients in Pakistan: a systematic review. Cureus. 2020 Aug; 12(8). doi: 10.7759/cureus.10070. DOI: https://doi.org/10.7759/cureus.10070

El Goundali K, Chebabe M, Laamiri FZ, Hilali A. The determinants of consanguineous marriages among the Arab population: a systematic review. Iranian Journal of Public Health. 2022 Feb; 51(2): 253. doi: 10.18502/ijph.v51i2.8679. DOI: https://doi.org/10.18502/ijph.v51i2.8679

Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Deutsches Ärzteblatt International. 2011 Aug; 108(31-32): 532. doi: 10.3238/arztebl.2011.0532. DOI: https://doi.org/10.3238/arztebl.2011.0532

Mir SA, Alshehri BM, Alaidarous M, Banawas SS, Dukhyil AA, Alturki MK. Prevalence of hemoglobinopathies (β-thalassemia and sickle cell trait) in the adult population of Al Majma’ah, Saudi Arabia. Hemoglobin. 2020 Jan; 44(1): 47-50. doi: 10.1080/03630269.2020.1729175. DOI: https://doi.org/10.1080/03630269.2020.1729175

Shabbir S, Nadeem M, Sattar A, Ara I, Ansari S, Farzana T et al. Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan. Cogent Medicine. 2016 Dec; 3(1): 1188875. doi: 10.1080/2331205X.2016.1188875. DOI: https://doi.org/10.1080/2331205X.2016.1188875

Khan K and Zahoor S. Pattern of Hemoglobinopathies on HPLC among patients referred to selected centers in Peshawar, Pakistan. Rawal Medical Journal. 2018 Oct; 43(4): 623-6.

Waheed U, Satti HS, Farooq N, Zaheer HA. Frequency of haemoglobinopathies: a single-centre, cross-sectional study from Islamabad, Pakistan. EMHJ-Eastern Mediterranean Health Journal. 2012; 18(12): 1257-9. doi: 10.26719/2012.18.12.1257. DOI: https://doi.org/10.26719/2012.18.12.1257

Riaz H, Shah MA, Rehan G, Azeem R. Types and frequency of hemoglobinopathies, diagnosed by HB electrophoreses in the lady reading hospital Peshawar, Pakistan. Khyber Journal of Medical Sciences. 2020 Jan; 13(1): 39-42.